IDRA News and Press, Idera Pharmaceuticals Inc. From 05/18/22

Are These Penny Stocks on Your Buy List Right Now? With another day of bearish trading patterns for penny stocks and blue chips, there is a lot for traders to know. As a result of the past few months of trading penny stocks , most investors are eager to see bullish trading patterns....

NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Brickell Biotech (NASDAQ: BBI), Idera Pharmaceuticals (...

The clinical-stage biotech Idera Pharmaceuticals (NASDAQ:IDRA) announced on Tuesday that investigators have decided to conclude a Phase 2 trial for the company’s cancer candidate tilsotolimod in melanoma after positive interim results. Idera (IDRA) shares have surged ~68% in ...

EXTON, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” “we,” and “our”) (Nasdaq: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sp...

EXTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the first quarter ended March...

Has the stock market bottomed? That’s what some traders are weighing right now against a backdrop of new earnings data and Fed speak. Meanwhile, small-caps, micro-caps, and penny stocks remain a hot topic among retail traders. Other than their ability to record significant ga...

Idera Pharmaceuticals press release (NASDAQ:IDRA): Q4 GAAP EPS of -$0.08. The company's cash position as of December 31, 2021 was $32.5 million For further details see: Idera Pharmaceuticals GAAP EPS of -$0.08

EXTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the fourth quarter and year...

Trading Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks and blue chips here and in full effect, there is a lot for investors to keep track of. While volatility remains extremely high right now, having a consistent understanding of the lat...

Updating the progress of clinical trials for the company’s Toll-like receptor 9 agonist, tilsotolimod, Idera Pharmaceuticals (NASDAQ:IDRA) said that its partner AbbVie (NYSE:ABBV) has discontinued further patient enrollment in an early-stage study for a combination therapy involving th...